The total synthesis of (+)-dragmacidin F NK Garg, DD Caspi, BM Stoltz Journal of the American Chemical Society 126 (31), 9552-9553, 2004 | 237 | 2004 |
Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A DA DeGoey, JT Randolph, D Liu, J Pratt, C Hutchins, P Donner, ... Journal of medicinal chemistry 57 (5), 2047-2057, 2014 | 147 | 2014 |
Development of an enantiodivergent strategy for the total synthesis of (+)-and (−)-dragmacidin F from a single enantiomer of quinic acid NK Garg, DD Caspi, BM Stoltz Journal of the American Chemical Society 127 (16), 5970-5978, 2005 | 138 | 2005 |
Anti-viral compounds DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ... US Patent 8,691,938, 2014 | 121 | 2014 |
The palladium‐catalyzed aerobic kinetic resolution of secondary alcohols: reaction development, scope, and applications DC Ebner, JT Bagdanoff, EM Ferreira, RM McFadden, DD Caspi, ... Chemistry–A European Journal 15 (47), 12978-12992, 2009 | 96 | 2009 |
The resolution of important pharmaceutical building blocks by palladium‐catalyzed aerobic oxidation of secondary alcohols DD Caspi, DC Ebner, JT Bagdanoff, BM Stoltz Advanced Synthesis & Catalysis 346 (2‐3), 185-189, 2004 | 72 | 2004 |
Kinetic Modeling of the Nickel-Catalyzed Esterification of Amides NA Weires, DD Caspi, NK Garg ACS Catalysis 7, 4381–4385, 2017 | 69 | 2017 |
Anti-Viral Compounds DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ... US Patent App. 12/903,822, 2011 | 61 | 2011 |
Process development of ABT-450–A first generation NS3/4A protease inhibitor for HCV DD Caspi, RD Cink, D Clyne, M Diwan, KM Engstrom, T Grieme, J Mei, ... Tetrahedron 75 (32), 4271-4286, 2019 | 18 | 2019 |
Heterogeneous Reductive Isomerization Reaction Using Catalytic Pd/C and H2 DD Caspi, NK Garg, BM Stoltz Organic Letters 7 (12), 2513-2516, 2005 | 18 | 2005 |
The utility of the classical and oxidative Heck reactions in natural product synthesis: studies directed toward the total synthesis of dragmacidin F NK Garg, DD Caspi, BM Stoltz Synlett 2006 (18), 3081-3087, 2006 | 17 | 2006 |
Quantitative impurity rejection analysis for crystallization DD Caspi, FL Nordstrom Organic Process Research & Development 22 (7), 856-861, 2018 | 9 | 2018 |
Continuous multiphase flow nitration and cryogenic flow formylation: enabling process development and manufacturing of pharmaceutical intermediates B Cardinal-David, KC Harper, A Verma, D Hanna, DD Caspi, C Vitale, ... Organic Process Research & Development 25 (11), 2473-2481, 2021 | 6 | 2021 |
Anti-viral compounds DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ... | 6 | 2019 |
Rapid and Convergent Synthesis of a 2,4’-Linked Tri-oxazole in an Approach to Poly-oxazoles DD Caspi, H Zhang, SC Virgil, FM Piller, BM Stoltz Heterocycles 86 (2), 1003-1008, 2012 | 6 | 2012 |
Direct Preparation of Indole Hemiaminals through Organocatalytic Nucleophilic Addition of Indole to Aldehydes N Zhang, Y Li, Z Chen, W Qin Synthesis 50 (20), 4063-4070, 2018 | 4 | 2018 |
Anti-viral compounds R Wagner, JK Pratt, D Liu, MD Tufano, DA Degoey, WM Kati, ... US Patent 9,006,387, 2015 | 4 | 2015 |
Anti-viral compounds DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ... | 3 | 2012 |
Development of an Operational Space Using Mechanistic Models for a Pd-Catalyzed Amidation Reaction Used in the Synthesis of ABT-530 DD Caspi, M Diwan, JCC Califano, DJ Mack, S Shekhar Organic Process Research & Development 23 (8), 1509-1521, 2019 | 2 | 2019 |
Potassium tert-Amylate: A Cautionary Tale DD Caspi, SM Richter The Journal of Organic Chemistry 84 (12), 8256-8258, 2019 | 2 | 2019 |